Ulvi Bayraktutan is an Associate Professor at the Academic Unit of Mental Health and Clinical Neurosciences at the University of Nottingham. His research aims to develop clinical biomarkers and novel therapeutics for (physio)pathological conditions associated with neurodegeneration and/or endothelial dysfunction, notably stroke, hypertension, diabetes and ageing. He performs preclinical, translational and clinical research to achieve these goals.
He acts as a reviewer for many high profile international journals and is an editorial board member of five different journals. He provides expert opinion or advice to a number of national and international research councils, charities, healthcare companies, societies and institutions.
He has been a Fellow of Higher Education Academy (FHEA) since 2007 and supervised many postgraduate studies for the degrees of MSc, MD and PhD.
Dr Bayraktutan is the Chief investigator of the Dunhill Medical Trust EPC study investigating the specific effect of ageing on the circulatory level and functional aspects of endothelial progenitor cells as well as the diagnostic and prognostic value of endothelial progenitor cells in elderly patients with lacunar or cortical stroke.
Find out more:
Stroke, blood-brain barrier, stem cells, endothelial progenitor cells, regenerative medicine, cell-based and cell-free therapeutic approaches, novel therapeutics, neurodegeneration, neurovascular protection, ageing, age-related diseases, clinical biomarkers, senescence, cell biology, hypothermia, endothelial (dys)function, cytoskeleton, apoptosis, oxidative stress, experimental models of human disease and molecular biology.
Molecular Basis of Disease,
Atrial Fibrillation and Stroke,
Blood-Brain Barrier in Stroke Medicine and Research,
BMedSci projects (lab-based or literature review-based)
Postgraduate student teaching,
· Molecular mechanisms of neurodegenerative diseases - stroke and multiple sclerosis
· Role of endothelial cell senescence in ageing and neurodegenerative diseases
· Regenerative medicine
· Identification and application of novel therapeutics for neurovascular conditions
· Clinical biomarkers
· Pioneering in vitro models of human cerebral disease
ABDULKADIR, RR, ALWJWAJ, M, RAKKAR, K and OTHMAN, OA, Outgrowth Endothelial Cell Conditioned Medium Negates TNF-alpha-Evoked Cerebral Barrier Damage: A Reverse Translational Research to Explore Mechanisms Stem Cell Reviews and Reports. (In Press.)